The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...
For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not ...
In a synopsis of a clinical practice guideline issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Feb. 17 in the Annals of Internal Medicine, updated ...
Did you know that the Grammy-award winning singer, P!NK, has asthma? Pink, whose real name is Alecia Beth Moore-Hart, has revealed she has had the chronic illness for years. In December 2009, she ...
Introduction and Objectives Biologic therapies have transformed severe asthma management, enabling improved control and reduced exacerbations. The Global Initiative for Asthma (GINA) guidelines 1 ...
Arjun Mohan received funding from Verona Pharm LLC and Regeneron Pharm for Consulting Services (one time, relationship has ended). These services have no conflict with the article written here ...
As reviewed in Treatment Options, current management options for presbyopia cover a wide range of wearables, topical pharmaceuticals, surgical interventions and other approaches that differ markedly ...
Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...
Glenview, Illinois –The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in severe asthma. Published in the journal CHEST ®, the ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results